The goal of this study was to analyze antibody responses to Plasmodium falciparum glutamate-rich protein (GLURP) using clinical data and plasma samples obtained from villagers of Dielmo, Senegal. This molecule was chosen because it is targeted by human antibodies which induce parasite growth inhibition in antibodydependent cellular inhibition (ADCI) assays. The results showed a strong correlation between protection against malaria attacks and levels of immunoglobulin G2 (IgG2) and IgG3 against GLURP 94-489 (R0) and IgG3 against GLURP 705-1178 (R2) when corrected for the confounding effect of age-related exposure to malaria. Thus, GLURP may play a role in the induction of protective immunity against P. falciparum malaria.Individuals repeatedly exposed to Plasmodium falciparum malaria infections gradually develop clinical immunity. Results from studies performed in vivo suggest that one of the mechanisms underlying clinical immunity to malaria is the containment of parasite multiplication by antibodies (12,13,15). It is reasonable to assume that if protective effects are mediated by antibodies, there is a relationship between the level, isotype, or function of the antibodies and the clinical outcome. Studies of the role of subclass responses in naturally developing clinical immunity to defined malaria antigens and fragments thereof are therefore important. Bouharoun-Tayoun and Druilhe found profound differences in the distribution of immunoglobulin (Ig) subclasses between clinically protected and nonprotected individuals, with cytophilic isotypes (IgG1 and IgG3) being dominant in protected individuals (5). This observation was later confirmed by Aribot (1), who found that the level of parasitespecific IgG3, but not total IgG, was inversely proportional to susceptibility to clinical malaria. In a study of severe malaria, Sarthou et al. demonstrated that only levels of P. falciparumspecific IgG3 were positively correlated with survival (16).The glutamate-rich protein (GLURP) of P. falciparum is synthesized during all stages of the parasite in the vertebrate host, including on the surface of newly released merozoites (2). Immunoepidemiological studies have demonstrated a high prevalence of antibodies against recombinant GLURP fragments in adults from Liberia (20) and have shown that GLURPspecific IgG was associated with low parasite densities (10, 11) and the absence of disease (8) in West African children.Motivated by these results and our recent findings that highly affinity-purified human IgG antibodies to GLURP were able to promote a strong monocyte-dependent inhibition of P. falciparum growth in vitro (19), we have investigated the distribution of isotypes to nonrepetitive and repetitive regions of GLURP in plasma from 214 villagers in Dielmo, Senegal, and its correlation to clinical protection.